300146 汤臣倍健
已收盘 11-22 15:00:00
资讯
新帖
简况
汤臣倍健业绩大跳水：前三季度净利“腰斩”，主品牌收入缩水近三成
证券之星 · 11-08
汤臣倍健业绩大跳水：前三季度净利“腰斩”，主品牌收入缩水近三成
11月7日汤臣倍健涨5.23%，体育LOF基金重仓该股
证券之星 · 11-07
11月7日汤臣倍健涨5.23%，体育LOF基金重仓该股
汤臣倍健涨5.23%，国元证券一周前给出“买入”评级
证券之星 · 11-07
汤臣倍健涨5.23%，国元证券一周前给出“买入”评级
汤臣倍健：银华基金、财通证券等多家机构于11月6日调研我司
证券之星 · 11-07
汤臣倍健：银华基金、财通证券等多家机构于11月6日调研我司
MSCI重大调整！券商股最受青睐，20家公司遭剔除
格隆汇 · 11-07
MSCI重大调整！券商股最受青睐，20家公司遭剔除
【机构调研记录】银华基金王海峰调研汤臣倍健
证券之星 · 11-07
【机构调研记录】银华基金王海峰调研汤臣倍健
MSCI中国旗舰指数调整：青睐券商 剔除20只股票
美港电讯 · 11-07
MSCI中国旗舰指数调整：青睐券商 剔除20只股票
汤臣倍健，麻烦了
市场资讯 · 11-06
汤臣倍健，麻烦了
A股食品股午后拉升走强，朱老六、黑芝麻3连板，汤臣倍健、千禾味业、紫燕食品、良品铺子等跟涨。
美港电讯 · 11-05
A股食品股午后拉升走强，朱老六、黑芝麻3连板，汤臣倍健、千禾味业、紫燕食品、良品铺子等跟涨。
天风证券：给予汤臣倍健增持评级
证券之星 · 11-01
天风证券：给予汤臣倍健增持评级
管理人员占比近半、研发投入显著偏低！汤臣倍健梁允超如何重塑产品力？
市场资讯 · 10-29
管理人员占比近半、研发投入显著偏低！汤臣倍健梁允超如何重塑产品力？
国元证券：给予汤臣倍健买入评级
证券之星 · 10-29
国元证券：给予汤臣倍健买入评级
汤臣倍健：10月25日接受机构调研，BRILLIANCE - BRILLIANT PARTNERS FUND LP、Pleiad Investment Advisors Limited等多家机构参与
证券之星 · 10-28
汤臣倍健：10月25日接受机构调研，BRILLIANCE - BRILLIANT PARTNERS FUND LP、Pleiad Investment Advisors Limited等多家机构参与
汤臣倍健（300146）2024年三季报简析：净利润减54.31%，盈利能力上升
证券之星 · 10-27
汤臣倍健（300146）2024年三季报简析：净利润减54.31%，盈利能力上升
汤臣倍健(300146)9月30日股东户数6.92万户，较上期增加3.99%
证券之星 · 10-26
汤臣倍健(300146)9月30日股东户数6.92万户，较上期增加3.99%
汤臣倍健(300146.SZ)发布前三季度业绩，净利润8.69亿元，下降54.31%
智通财经 · 10-25
汤臣倍健(300146.SZ)发布前三季度业绩，净利润8.69亿元，下降54.31%
业绩滑铁卢的“保健品一哥”汤臣倍健：重金营销战法失灵，三大品牌全线尽墨
证券之星 · 10-14
业绩滑铁卢的“保健品一哥”汤臣倍健：重金营销战法失灵，三大品牌全线尽墨
10月8日汤臣倍健涨7.38%，交银内需增长一年持有混合基金重仓该股
证券之星 · 10-08
10月8日汤臣倍健涨7.38%，交银内需增长一年持有混合基金重仓该股
汤臣倍健涨7.38%，国元证券二个月前给出“买入”评级
证券之星 · 10-08
汤臣倍健涨7.38%，国元证券二个月前给出“买入”评级
汤臣倍健(300146.SZ)累计回购1573.7万股 耗资2.5亿元
智通财经 · 10-08
汤臣倍健(300146.SZ)累计回购1573.7万股 耗资2.5亿元
公司概况
公司名称：
汤臣倍健股份有限公司
所属行业：
食品制造业
上市日期：
2010-12-15
主营业务：
汤臣倍健股份有限公司是膳食营养补充剂的研发、生产和销售。主要产品涵盖了片剂、粉剂、胶囊。公司拥有158个保健食品注册批准证书及178个保健食品备案凭证。汤臣倍健透明工厂入选国家工业和信息化部“2022年度智能制造示范工厂揭榜单位”，成为全国唯一一家入选的膳食营养补充剂智能制造示范工厂；荣获国家工业和信息化部“绿色工厂”、珠海市市长质量奖、2023年全国质量标杆等。
发行价格：
110.00
{"stockData":{"symbol":"300146","market":"SZ","secType":"STK","nameCN":"汤臣倍健","latestPrice":12.4,"timestamp":1732259001000,"preClose":12.93,"halted":0,"volume":19916422,"delay":0,"floatShares":1130000000,"shares":1701000000,"eps":0.4197,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.53,"latestTime":"11-22 15:00:00","open":12.92,"high":12.95,"low":12.39,"amount":252000000,"amplitude":0.0433,"askPrice":12.41,"askSize":905,"bidPrice":12.4,"bidSize":481,"shortable":0,"etf":0,"ttmEps":0.4197,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":12.93,"symbolType":"stock","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":14.22,"lowLimit":11.64,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1700845431,"pbRate":1.94,"roa":"--","roe":"7.5%","epsLYR":1.03,"committee":-0.349754,"marketValue":21090000000,"floatMarketCap":14012000000,"peRate":29.544913,"changeRate":-0.041,"turnoverRate":0.0176,"status":1},"requestUrl":"/m/hq/s/300146/wiki","defaultTab":"wiki","newsList":[{"id":"2481601164","title":"汤臣倍健业绩大跳水：前三季度净利“腰斩”，主品牌收入缩水近三成","url":"https://stock-news.laohu8.com/highlight/detail?id=2481601164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481601164?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:16","pubTimestamp":1731032182,"startTime":"0","endTime":"0","summary":"今年前三季度，汤臣倍健业绩大幅跳水，其中归母净利润出现“腰斩”。证券之星注意到，经营数据不给力之下，汤臣倍健三大主营品牌收入均出现“萎缩”，其中主品牌“汤臣倍健”收入降幅近三成。这是近十年来，汤臣倍健交出最差的一份中报成绩单。到了第三季度，汤臣倍健的营收数据进一步下降，归母净利润更是出现负值，同比下滑106.3%。今年9月，汤臣倍健披露的进展公告显示，2023年6月，可售物业交付，本次交易第一阶段已完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024110800011320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0226","BK0107","BK0114","BK0146","300146","BK0028"],"gpt_icon":0},{"id":"2481010926","title":"11月7日汤臣倍健涨5.23%，体育LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481010926","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481010926?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:20","pubTimestamp":1730967639,"startTime":"0","endTime":"0","summary":"证券之星消息，11月7日汤臣倍健涨5.23%，收盘报13.89元，换手率4.89%，成交量55.2万手，成交额7.54亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为体育LOF。体育LOF目前规模为1.27亿元，最新净值0.899，较上一交易日上涨1.93%，近一年下跌0.99%。体育LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700026478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0107","BK0028","BK0226","BK0146","BK0042","161030","BK0114"],"gpt_icon":0},{"id":"2481929819","title":"汤臣倍健涨5.23%，国元证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481929819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481929819?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:20","pubTimestamp":1730967631,"startTime":"0","endTime":"0","summary":"今日汤臣倍健涨5.23%，收盘报13.89元。2024年10月29日，国元证券研究员邓晖,朱宇昊,单蕾发布了对汤臣倍健的研报《2024年三季报点评：节奏调整，短期承压》，该研报对汤臣倍健给出“买入”评级。研报中预计公司2024-2026年归母净利润分别为7.44/11.43/14.42亿元，增速-57.39%/53.61%/26.17%，对应10月28日PE分别为30/19/15X，维持“买入”评级。汤臣倍健个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700026472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","000728"],"gpt_icon":0},{"id":"2481992783","title":"汤臣倍健：银华基金、财通证券等多家机构于11月6日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2481992783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481992783?lang=zh_cn&edition=full","pubTime":"2024-11-07 10:06","pubTimestamp":1730945172,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年11月6日汤臣倍健发布公告称银华基金王海峰 周晶 李爽、财通证券吴文德、海通证券程碧升、华创证券刘懿于2024年11月6日调研我司。问：公司收入占比超过 10%的品牌有哪些答：公司收入占比超过 10%的品牌有汤臣倍健、健力多、lifespace。汤臣倍健主营业务：膳食营养补充剂的研发、生产和销售。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700011006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300146","BK0028","601108","BK0042","BK0146","BK0114","BK0107","BK0276"],"gpt_icon":0},{"id":"2481992046","title":"MSCI重大调整！券商股最受青睐，20家公司遭剔除","url":"https://stock-news.laohu8.com/highlight/detail?id=2481992046","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481992046?lang=zh_cn&edition=full","pubTime":"2024-11-07 10:00","pubTimestamp":1730944800,"startTime":"0","endTime":"0","summary":"影响有多大？","market":"sg","thumbnail":"https://img3.gelonghui.com/345bf-73067240-edb6-4f25-9455-ceb5c116b47b.jpg?guru_height=896&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/345bf-73067240-edb6-4f25-9455-ceb5c116b47b.jpg?guru_height=896&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1282940","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK4112","LU0320765059.SGD","LU0289961442.SGD","BK0006","BK0146","BK0183","LU2265009873.SGD","LU1804176565.USD","BK1119","LU0672654240.SGD","LU2210150020.SGD","601866","300251","BK0020","BK0087","LU0109391861.USD","002372","300146","BK0049","BK1539","BK0196","BK0197","BK0215","BK0050","603589","BK0200","SG9999006597.SGD","BK0214","601136","BK0083","MSCI","BK0114","603296","BK0042","BK0028","LU0175139822.USD","BK0012","002739","BK0011","LU0289739343.SGD","LU2210149790.SGD","688047","BK0010","BK0107","BK0220","BK0267","601162","BK0188","LU2460026573.USD","02238"],"gpt_icon":0},{"id":"2481960138","title":"【机构调研记录】银华基金王海峰调研汤臣倍健","url":"https://stock-news.laohu8.com/highlight/detail?id=2481960138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481960138?lang=zh_cn&edition=full","pubTime":"2024-11-07 08:05","pubTimestamp":1730937901,"startTime":"0","endTime":"0","summary":"；公司业务范围主要包括水利相关的建设I程设计及咨询等。旗下最近一年表现最佳的公募基金产品为银华添泽定开债，最新单位净值为1.81，近一年增长62.28%。旗下最新募集公募基金产品为银华中证A500ETF发起式联接A，类型为指数型-股票，集中认购期2024年10月25日至2024年11月8日。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700006800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0114","BK0107","300146","BK0028","BK0146","BK0226"],"gpt_icon":0},{"id":"2481969729","title":"MSCI中国旗舰指数调整：青睐券商 剔除20只股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2481969729","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481969729?lang=zh_cn&edition=full","pubTime":"2024-11-07 06:58","pubTimestamp":1730933928,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["02238","BK0188","LU0630378692.HKD","BK0226","09888","601136","BK0049","89888","688047","BK0201","LU0543330566.HKD","LU0821914370.USD","603296","ACWI","BK0146","601162","LU0173614495.USD","BK1587","LU1267930730.SGD","LU0630378429.USD","LU2210150020.SGD","LU0039217434.USD","LU0856984785.SGD","LU1328615791.USD","LU2210149790.SGD","LU0823426308.USD","300251","603589","BK0107","MSCI","BK0012","LU0051755006.USD","BIDU","LU0287142896.SGD","LU0072462343.USD","LU0043850808.USD","LU2265009873.SGD","LU0819121731.USD","000703","LU2095319765.USD","LU0417516738.SGD","IQ","BK0108","LU1023057109.AUD","BK1609","BK0183","601238","300146","BK0264","BK4112"],"gpt_icon":0},{"id":"2481614657","title":"汤臣倍健，麻烦了","url":"https://stock-news.laohu8.com/highlight/detail?id=2481614657","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481614657?lang=zh_cn&edition=full","pubTime":"2024-11-06 12:34","pubTimestamp":1730867640,"startTime":"0","endTime":"0","summary":" 有“保健品一哥”之称的汤臣倍健，在“双11”期间就杀红了眼。11月2日凌晨3点左右，汤臣倍健官方旗舰店蛋白粉的直播间，面容姣好的女主播卖力介绍着蛋白粉产品。 女主播在直播间里表示，汤臣倍健近期会24小时不间断直播。 主播们卖力营销，但是汤臣倍健的业绩却爆雷了。 令人担忧的是，10月26日，汤臣倍健发布的公司三季报成绩单也没有出现反转，而是延续了过去半年的颓势。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/wm/2024-11-06/doc-incvaynm8777444.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-11-06/doc-incvaynm8777444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300146","BK0114","BK0226","BK0028","BK0107","BK0146","BK0042"],"gpt_icon":0},{"id":"2481651733","title":"A股食品股午后拉升走强，朱老六、黑芝麻3连板，汤臣倍健、千禾味业、紫燕食品、良品铺子等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2481651733","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481651733?lang=zh_cn&edition=full","pubTime":"2024-11-05 13:22","pubTimestamp":1730784155,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0114","BK0107","603027","603057","BK0226","BK0132","603719","159982","000716","BK0209","BK0238","BK0201","BK0028","300146","BK0042","399300","BK0146","BK0077"],"gpt_icon":0},{"id":"2480788128","title":"天风证券：给予汤臣倍健增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480788128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480788128?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:55","pubTimestamp":1730469355,"startTime":"0","endTime":"0","summary":"天风证券股份有限公司吴立,张潇倩,陈潇近期对汤臣倍健进行研究并发布了研究报告《单品调整接近尾声，改革成效兑现可期》，本报告对汤臣倍健给出增持评级，当前股价为12.62元。下调至“增持”评级。最新盈利预测明细如下：该股最近90天内共有11家机构给出评级，买入评级6家，增持评级4家，中性评级1家；过去90天内机构目标均价为14.89。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100048060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601162","300146"],"gpt_icon":0},{"id":"2479041068","title":"管理人员占比近半、研发投入显著偏低！汤臣倍健梁允超如何重塑产品力？","url":"https://stock-news.laohu8.com/highlight/detail?id=2479041068","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479041068?lang=zh_cn&edition=full","pubTime":"2024-10-29 12:05","pubTimestamp":1730174700,"startTime":"0","endTime":"0","summary":" 10月25日晚，汤臣倍健发布最新财报。今年第三季度，汤臣倍健实现营收11.2亿元，同比下降48.76%；归属于上市公司股东的净利润-2241万，同比下降106.3%；归属于上市公司股东的扣非净利润为-2415万，同比下降107%。 然而，这并非汤臣倍健首次出现业绩下滑。2024年上半年，汤臣倍健营业收入同比下降17.56%，净利润同比下降43.81%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-10-29/doc-incuetkc8896359.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-10-29/doc-incuetkc8896359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0107","BK0146","BK0114","300146","BK0028","BK0042","BK0226"],"gpt_icon":0},{"id":"2479495806","title":"国元证券：给予汤臣倍健买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479495806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479495806?lang=zh_cn&edition=full","pubTime":"2024-10-29 08:27","pubTimestamp":1730161677,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司邓晖,朱宇昊,单蕾近期对汤臣倍健进行研究并发布了研究报告《2024年三季报点评：节奏调整，短期承压》，本报告对汤臣倍健给出买入评级，当前股价为13.06元。 投资建议 我们预计公司2024-2026年归母净利润分别为7.44/11.43/14.42亿元，增速-57.39%/53.61%/26.17%，对应10月28日PE分别为30/19/15X，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有11家机构给出评级，买入评级6家，增持评级4家，中性评级1家；过去90天内机构目标均价为14.89。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900008711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","000728"],"gpt_icon":0},{"id":"2478114492","title":"汤臣倍健：10月25日接受机构调研，BRILLIANCE - BRILLIANT PARTNERS FUND LP、Pleiad Investment Advisors Limited等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2478114492","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478114492?lang=zh_cn&edition=full","pubTime":"2024-10-28 09:42","pubTimestamp":1730079736,"startTime":"0","endTime":"0","summary":"第三季度仍延续半年度趋势。上述经营调整对公司业绩带来较大的压力和影响。汤臣倍健主营业务：膳食营养补充剂的研发、生产和销售。汤臣倍健2024年三季报显示，公司主营收入57.34亿元，同比下降26.33%；归母净利润8.69亿元，同比下降54.31%；扣非净利润8.07亿元，同比下降55.11%；其中2024年第三季度，公司单季度主营收入11.2亿元，同比下降48.76%；单季度归","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800003494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0107","BK0114","BK0146","BK0042","300146","BK0028"],"gpt_icon":0},{"id":"2478184805","title":"汤臣倍健（300146）2024年三季报简析：净利润减54.31%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2478184805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478184805?lang=zh_cn&edition=full","pubTime":"2024-10-27 10:58","pubTimestamp":1729997900,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期汤臣倍健发布2024年三季报。截至本报告期末，公司营业总收入57.34亿元，同比下降26.33%，归母净利润8.69亿元，同比下降54.31%。本报告期汤臣倍健盈利能力上升，毛利率同比增幅1.02%，净利率同比增幅15.87%。去年的净利率为18.91%，算上全部成本后，公司产品或服务的附加值高。持有汤臣倍健最多的基金为体育LOF，目前规模为1.27亿元，最新净值0.866，较上一交易日上涨2.24%，近一年上涨2.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700011298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146"],"gpt_icon":0},{"id":"2478942982","title":"汤臣倍健(300146)9月30日股东户数6.92万户，较上期增加3.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478942982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478942982?lang=zh_cn&edition=full","pubTime":"2024-10-26 17:03","pubTimestamp":1729933409,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汤臣倍健披露，截至2024年9月30日公司股东户数为6.92万户，较6月30日增加2653.0户，增幅为3.99%。在食品加工行业个股中，汤臣倍健股东户数高于行业平均水平，截至9月30日，食品加工行业平均股东户数为3.45万户。从股价来看，2024年6月30日至2024年9月30日，汤臣倍健区间涨幅为9.96%，在此期间股东户数增加2653.0户，增幅为3.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102600008556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300146","BK0042","BK0114","BK0107","BK0146","BK0226"],"gpt_icon":0},{"id":"2478982321","title":"汤臣倍健(300146.SZ)发布前三季度业绩，净利润8.69亿元，下降54.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478982321","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478982321?lang=zh_cn&edition=full","pubTime":"2024-10-25 20:45","pubTimestamp":1729860312,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汤臣倍健(300146.SZ)发布2024年三季度报告，该公司前三季度营业收入为57.34亿元，同比减少26.33%。归属于上市公司股东的净利润为8.69亿元，同比减少54.31%。归属于上市公司股东的扣除非经常性损益的净利润为8.07亿元，同比减少55.11%。基本每股收益为0.51元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300146"],"gpt_icon":0},{"id":"2475337202","title":"业绩滑铁卢的“保健品一哥”汤臣倍健：重金营销战法失灵，三大品牌全线尽墨","url":"https://stock-news.laohu8.com/highlight/detail?id=2475337202","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475337202?lang=zh_cn&edition=full","pubTime":"2024-10-14 16:43","pubTimestamp":1728895430,"startTime":"0","endTime":"0","summary":"证券之星注意到，汤臣倍健上半年营收下滑背后，或在于品牌老化，其三大主营品牌收入均出现“萎缩”。为了抢占市场，汤臣倍健舍得在营销上砸钱。上市首年，汤臣倍健的营收不过3.46亿元，归母净利润只有9210万元。在行业人士看来，汤臣倍健业绩下滑的真正原因或在于品牌老化。今年上半年，汤臣倍健今年上半年销售费用为18.22亿元，和去年同期基本持平。根据汤臣倍健披露的销售费用表显示，平台费用和广告费是两项最大的支出。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024101400020265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0042","BK0028","BK0107","BK0226","BK0114","BK0146"],"gpt_icon":0},{"id":"2473446196","title":"10月8日汤臣倍健涨7.38%，交银内需增长一年持有混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473446196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473446196?lang=zh_cn&edition=full","pubTime":"2024-10-08 17:37","pubTimestamp":1728380257,"startTime":"0","endTime":"0","summary":"证券之星消息，10月8日汤臣倍健涨7.38%创60日新高，收盘报16.0元，换手率8.2%，成交量92.66万手，成交额15.26亿元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为交银内需增长一年持有混合。交银内需增长一年持有混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800026419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0042","BK0226","BK0146","BK0028","BK0107","300146"],"gpt_icon":0},{"id":"2473446143","title":"汤臣倍健涨7.38%，国元证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2473446143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473446143?lang=zh_cn&edition=full","pubTime":"2024-10-08 17:37","pubTimestamp":1728380251,"startTime":"0","endTime":"0","summary":"今日汤臣倍健涨7.38%，收盘报16.0元。2024年8月7日，国元证券研究员邓晖,朱宇昊发布了对汤臣倍健的研报《汤臣倍健2024年中报点评：同期高基数，核心单品迭代升级》，该研报对汤臣倍健给出“买入”评级。研报中预计公司2024-2026年归母净利润分别为11.45/14.11/16.45亿元，增速-34.44%/23.25%/16.57%，对应8月6日PE分别为18/15/12X，维持“买入”评级。汤臣倍健个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800026416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728","300146"],"gpt_icon":0},{"id":"2473443375","title":"汤臣倍健(300146.SZ)累计回购1573.7万股 耗资2.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473443375","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473443375?lang=zh_cn&edition=full","pubTime":"2024-10-08 17:06","pubTimestamp":1728378394,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汤臣倍健(300146.SZ)公告，截至2024年9月30日，公司第一期回购已通过回购专用账户以集中竞价交易方式累计回购股份1573.7万股，支付总金额为人民币2.5亿元(不含交易费用)。同时，公司尚未实施第二期回购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1191017.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","BK0226","BK0107","BK0114","BK0146","300146","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-12-15","address":"广东省珠海市金湾区三灶科技工业园星汉路19号","stockEarnings":[{"period":"1week","weight":-0.0388},{"period":"1month","weight":-0.0534},{"period":"3month","weight":0.1324},{"period":"6month","weight":-0.1842},{"period":"1year","weight":-0.283},{"period":"ytd","weight":-0.2296}],"companyName":"汤臣倍健股份有限公司","boardCode":"AI0014","perCapita":"16335股","boardName":"食品制造业","registeredCapital":"170084万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":" 汤臣倍健股份有限公司是膳食营养补充剂的研发、生产和销售。主要产品涵盖了片剂、粉剂、胶囊。公司拥有158个保健食品注册批准证书及178个保健食品备案凭证。汤臣倍健透明工厂入选国家工业和信息化部“2022年度智能制造示范工厂揭榜单位”，成为全国唯一一家入选的膳食营养补充剂智能制造示范工厂；荣获国家工业和信息化部“绿色工厂”、珠海市市长质量奖、2023年全国质量标杆等。","serverTime":1732329201538,"listedPrice":110,"stockholders":"69172人(较上一季度增加3.99%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汤臣倍健,300146,汤臣倍健股票,汤臣倍健股票老虎,汤臣倍健股票老虎国际,汤臣倍健行情,汤臣倍健股票行情,汤臣倍健股价,汤臣倍健股市,汤臣倍健股票价格,汤臣倍健股票交易,汤臣倍健股票购买,汤臣倍健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}